Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04933643
Other study ID # 2020SDU-QILU-072
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 22, 2021
Est. completion date March 2023

Study information

Verified date February 2023
Source Shandong University
Contact Li Yanqing
Phone 053182169385
Email liyanqing@sdu.edu.cn
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The invention of magnetically controlled capsule gastroscopy makes the movement of capsule endoscope in the body controllable. Endoscopic doctors can adjust the angle of capsule observation to examine gastric mucosa according to the need of examination. However, The presence of food residue, air bubbles, mucus and bile in the gastric cavity will affect the observation of gastric mucosa by capsule endoscopy. it will reduce the completion rate of capsule endoscopy, and even lead to misdiagnosis and missed diagnosis. The purpose of this study is to explore the factors affecting the quality of gastroscopy gastric environmental preparation of magnetically capsule.


Description:

Magnetically controlled capsule endoscopy is different from ordinary electronic gastroenteroscopy, it can not fill and clean the gastric cavity by water injection. The presence of food residue, air bubbles, mucus and bile in the gastric cavity will affect the observation of gastric mucosa by capsule endoscopy, reduce the completion rate of capsule endoscopy, and even lead to misdiagnosis and missed diagnosis, so the quality of MCCG gastric environmental preparation is an important factor limiting the accuracy of diagnosis of gastric lesions. We design the case report table by consulting the literature, and then collect patient information, and speculate the relevant influencing factors through the evaluation of the quality of gastric environmental preparation of the examination results. the ultimate goal is to reduce the missed diagnosis rate and misdiagnosis rate and the waste of clinical resources, to prepare the gastric environment more pertinently, and to provide certain guiding significance for the preparation of gastric environment in clinical magnetically controlled capsule endoscopy.


Recruitment information / eligibility

Status Recruiting
Enrollment 240
Est. completion date March 2023
Est. primary completion date August 1, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - patients aged 18-75 years old who intend to undergo magnetron capsule gastroscopy, regardless of gender - sign informed consent form Exclusion Criteria: - dysphagia, known or suspected gastrointestinal obstruction?stricture and fistula - patients with severe somatic diseases unable to complete examination - known active upper gastrointestinal bleeding - previous history of upper digestive tract or abdominal surgery to change - gastrointestinal anatomy - patients with cardiac pacemakers or implanted with other electronic medical - instruments and magnetic metal foreign bodies - pregnant women - claustrophobia or other mental disorders uncontrollable

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
China Department of Gastroenterology, Qilu Hospital, Shandong University Jinan Shandong

Sponsors (1)

Lead Sponsor Collaborator
Shandong University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary GCS score was used to evaluate the quality of gastric preparation GCS score was used to evaluate the quality of gastric preparation. GCS was defined as the sum of the scores of six major anatomical markers of the stomach (heart, fundus, body, horn, sinus, and pylorus).A 4-point grading system was used to define cleanliness as excellent (no mucus and foam attachment :4 points);Good (there is a small amount of mucus and foam, but it does not affect the test: score 3 points);Average (with a fair amount of mucus or foam).Failure to complete a completely reliable examination :2 points);Poor (large amount of mucus or foam residue :1 point).The GCS is the total score for all six landmarks, ranging from 6 (completely unprepared) to 24 (perfect).Gastric preparation was defined as sufficient when GCS=18 and insufficient when GCS<18. 24 months
Primary Questionnaire data were used to analyze the influencing factors Before the examination, the subjects were required to fill in a questionnaire about the influencing factors of the quality of stomach preparation. According to GCS, the subjects were divided into fully prepared group and inadequately prepared group. Finally, statistical analysis was used to find the influencing factors that had statistical significance with the quality of stomach preparation according to the questionnaire content. 24 months
Secondary The number of positive lesions The positive lesions detected in this study refer to some focal lesions of the stomach, including polyps, ulcers, gastric varices, submucosal tumors and so on.The lesions were identified by physicians who had performed magnetic capsule gastroscopy in more than 400 cases. 24 months
Secondary Number of participants with treatment-related adverse events as assessed by CTCAE v5.0 The safety of MCCG includes the acceptability or adverse events of MCCG preparation and examination, which is defined as symptoms or signs such as drinking water, examination and swallowing capsules, such as monitoring abdominal distension, nausea or vomiting.we count the number of participants with treatment-related adverse events as assessed by CTCAE v5.0 24 months
See also
  Status Clinical Trial Phase
Recruiting NCT02158260 - A New Method To Reduce Gastric Missing Areas in Capsule Endoscopy N/A
Completed NCT04605536 - Effect of Animation Video on the Success Rate of Children Swallowing Capsule Endoscopy N/A
Completed NCT04327869 - MCE Direct Visualization of Drug Behavior in Upper-gastrointestinal Tract
Recruiting NCT03351972 - Differences in Preparation for Small Bowel Capsule Endoscopy Phase 4
Recruiting NCT01783782 - Small Bowel Cleansing for Capsule Endoscopy in Pediatric Patients Phase 4
Completed NCT04671264 - Efficacy and Safety of Vibrating Capsule in Patients With Functional Constipation N/A
Completed NCT03662113 - Effect of Domperidone on Completion Rate of Vedio Capsule Endoscopy N/A
Completed NCT03977935 - The Second-Generation MCCG for Upper Gastrointestinal Tract. N/A
Recruiting NCT03441945 - Magnetic Steering Enhance Capsule Gastroscopy Gastric Emptying N/A
Completed NCT04389333 - Feasibility of Non-contact Magnetically-controlled Capsule Endoscopy During COVID-19 Pandemic N/A
Recruiting NCT04329468 - Detachable String MCE for Upper Gastrointestinal Tract and Small Bowel N/A
Completed NCT03482661 - Magnetic Steering Improves Small Bowel Capsule Endoscopy Completion Rate N/A
Recruiting NCT04970277 - Efficacy of Drinking Water During Capsule Endoscopy N/A
Completed NCT05073536 - Mini-sized MCE for Better Examination of UGI and Small Bowel N/A
Completed NCT03742934 - Short Peptide Formula for Bowel Preparation N/A
Completed NCT05228379 - Small Bowel Capsule Endoscopy: Experience From a Single Large Tertiary Care Centre
Recruiting NCT05249933 - Pronase Granules in Gastric Cleaning Phase 2/Phase 3
Completed NCT02382705 - SB3 Battery Life Observational Study
Recruiting NCT04032353 - Medical Consortium for Screening Upper Gastrointestinal Cancers With Magnetically Controlled Capsule Gastroscopy N/A
Completed NCT04479423 - The Usage of Soda-Water in Gastric Preparation for Magnetically Controlled Capsule Endoscopy N/A